Effect of pravastatin on cerebral infarcts and white matter lesions

被引:101
作者
ten Dam, VH
van den Heuvel, DMJ
van Buchem, MA
Westendorp, RGJ
Bollen, ELEM
Ford, I
de Craen, AJM
Blauw, GJ
机构
[1] Leiden Univ, Dept Gen Internal Med, NL-2300 RA Leiden, Netherlands
[2] Leiden Univ, Dept Radiol, NL-2300 RA Leiden, Netherlands
[3] Leiden Univ, Dept Neurol, NL-2300 RA Leiden, Netherlands
[4] N Glasgow Univ NHS Trust, Robertson Ctr Biostat, Glasgow, Lanark, Scotland
关键词
D O I
10.1212/01.WNL.0000161844.00797.73
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The authors examined the effect of pravastatin 40 mg daily on the progression of ischemic brain lesions using repeated brain MRI. After a mean treatment period of 33 months, there was an increase in total ischemic lesion load of 1.1 cm(3) (p < 0.001) in the 270 placebo-treated subjects and 1.1 cm(3) (p < 0.001) in the 265 pravastatin-treated subjects. There was no difference between the two treatment groups (p = 0.73).
引用
收藏
页码:1807 / 1809
页数:3
相关论文
共 10 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Stroke prevention, blood cholesterol, and statins [J].
Amarenco, P ;
Lavallée, P ;
Touboul, PJ .
LANCET NEUROLOGY, 2004, 3 (05) :271-278
[3]  
Collins R, 2004, LANCET, V363, P757
[4]   Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly - The Cardiovascular Health Study [J].
Longstreth, WT ;
Dulberg, C ;
Manolio, TA ;
Lewis, MR ;
Beauchamp, NJ ;
O'Leary, D ;
Carr, J ;
Furberg, CD .
STROKE, 2002, 33 (10) :2376-2382
[5]   Pathogenesis of leukoaraiosis - A review [J].
Pantoni, L ;
Garcia, JH .
STROKE, 1997, 28 (03) :652-659
[6]   The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].
Sacks, FM ;
Pfeffer, MA ;
Moye, LA ;
Rouleau, JL ;
Rutherford, JD ;
Cole, TG ;
Brown, L ;
Warnica, JW ;
Arnold, JMO ;
Wun, CC ;
Davis, BR ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009
[7]   Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [J].
Shepherd, J ;
Blauw, GJ ;
Murphy, MB ;
Bollen, ELEM ;
Buckley, BM ;
Cobbe, SM ;
Ford, I ;
Gaw, A ;
Hyland, M ;
Jukema, JW ;
Kamper, AM ;
Macfarlane, PW ;
Meinders, AE ;
Norrie, J ;
Packard, CJ ;
Perry, IJ ;
Stott, DJ ;
Sweeney, BJ ;
Twomey, C ;
Westendorp, RGJ .
LANCET, 2002, 360 (9346) :1623-1630
[8]   Different progression rates for deep white matter hyperintensities in elderly men and women [J].
van den Heuvel, DMJ ;
Admiraal-Behloul, F ;
ten Dam, VH ;
Olofsen, H ;
Bollen, ELEM ;
Murray, HM ;
Blauw, GJ ;
Westendorp, RGJ ;
de Craen, AJM ;
van Buchem, MA .
NEUROLOGY, 2004, 63 (09) :1699-1701
[9]   Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (≥12 months) follow-up intravascular ultrasound [J].
von Birgelen, C ;
Hartmann, M ;
Mintz, GS ;
Baumgart, D ;
Schmermund, A ;
Erbel, R .
CIRCULATION, 2003, 108 (22) :2757-2762
[10]   Pravastatin therapy and the risk of stroke. [J].
White, HD ;
Simes, RJ ;
Anderson, NE ;
Hankey, GJ ;
Watson, JDG ;
Hunt, D ;
Colquhoun, DM ;
Glasziou, P ;
MacMahon, S ;
Kirby, AC ;
West, MJ ;
Tonkin, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (05) :317-326